BeStock  
股票 › 生物科技 › IBRX

免疫生物 IBRX

美股市值排名 #1522生物科技昨日涨幅榜
$8.64 +$0.63 (+7.80%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $8.59 -0.48%
开盘$8.17
昨收$8.01
当日区间$7.88 – $8.69
成交量9.27M
市值$9.15B
市盈率(TTM)–
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$51.24M+93.9% YoY
营业利润-$61.70M+13.5% YoY
净利润-$230.39M-148.9% YoY
摊薄每股收益-$0.22-120.0% YoY
自由现金流-$70.03M+13.4% YoY
经营现金流-$66.49M

营收,近8个季度

$6.1MSep '24$7.6MDec '24$16.5MMar '25$26.4MJun '25$32.1MSep '25$38.3MDec '25$44.2MMar '26$51.2MJun '26

净利润,近8个季度

$-85.8MSep '24$-59.2MDec '24$-129.7MMar '25$-92.6MJun '25$-67.3MSep '25$-62.0MDec '25$-632.8MMar '26$-230.4MJun '26

各季度摊薄每股收益

-0.14Sep '24-0.09Dec '24-0.15Mar '25-0.10Jun '25-0.07Sep '25-0.06Dec '25-0.62Mar '26-0.22Jun '26

各季度自由现金流

$-101.6MSep '24$-87.3MDec '24$-87.0MMar '25$-80.8MJun '25$-69.7MSep '25$-71.7MDec '25$-77.1MMar '26$-70.0MJun '26

年度营收

$605.0KFY20$934.0KFY21$240.0KFY22$622.0KFY23$14.7MFY24$113.3MFY25

盈利能力与资产负债表

毛利率99.3%
营业利润率-151.9%
净利率-598.6%
资产收益率-192.6%
流动比率5.72
负债/资产比率266.4%
现金及投资$357.37M
总负债$805.55M
净现金(净负债)-$448.18M

营收构成

2026/Q2 季度

按业务线

  • Product revenue, net$50.67M 98.9%
  • Other revenues$568,000.00 1.1%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $51.24M $44.21M $113.29M $38.29M $32.06M
营业总收入 $51.24M $44.21M $113.29M $38.29M $32.06M
营业成本 $298,000.00 $238,000.00 $753,000.00 $382,000.00 $177,000.00
毛利润 $50.94M $43.97M $112.54M $37.90M $31.88M
营业费用 $112.64M $113.76M $368.56M $102.59M $87.51M
销售及管理费用 $51.82M $45.77M $150.00M $38.73M $36.28M
研发费用 $60.82M $67.99M $218.56M $63.86M $51.23M
营业利润 -$61.70M -$69.79M -$256.03M -$64.68M -$55.63M
非经营性利息净收入(支出) -$28.09M -$27.73M -$109.84M -$26.61M -$26.81M
非经营性利息收入 $3.16M $736,000.00 $2.69M $579,000.00 $772,000.00
非经营性利息支出 $31.24M $28.46M $112.53M $27.19M $27.58M
其他收入(支出) -$140.60M -$535.27M $14.26M $29.20M $15.13M
证券出售收益 -$44.88M -$292.73M $59.20M $31.06M $16.49M
其他非经营性收入(支出) -$95.72M -$242.54M -$44.95M -$1.86M -$1.36M
税前利润 -$230.39M -$632.79M -$351.61M -$62.09M -$67.31M
税费 $0.00 $9,000.00 -$135,000.00 -$135,000.00 -$35,000.00
净利润 -$230.39M -$632.80M -$351.47M -$61.96M -$67.27M
持续经营利润 -$230.39M -$632.80M -$351.47M -$61.96M -$67.27M
少数股东权益 -$12,000.00 -$15,000.00 -$74,000.00 -$14,000.00 -$21,000.00
归属母公司净利润 -$230.38M -$632.78M -$351.40M -$61.94M -$67.25M
归属普通股股东净利润 -$230.38M -$632.78M -$351.40M -$61.94M -$67.25M
基本每股收益 -$0.22 -$0.62 -$0.38 -$0.06 -$0.07
摊薄每股收益 -$0.22 -$0.62 -$0.38 -$0.06 -$0.07
权益法投资收益 – – $0.00 – –
特殊收益(费用) – – $0.00 – –
-减:资本性资产减值 – – $0.00 – –

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $628.50M $646.64M $501.90M $501.90M $518.99M
流动资产合计 $438.98M $452.95M $314.88M $314.88M $329.50M
现金及现金等价物与短期投资 $357.37M $380.88M $242.82M $242.82M $257.81M
-现金及现金等价物 $75.67M $205.19M $88.33M $88.33M $60.24M
-短期投资 $281.70M $175.69M $154.48M $154.48M $197.57M
应收款 $53.50M $43.27M $42.62M $42.62M $33.72M
-应收账款 $53.47M $43.27M $42.57M $42.57M $32.02M
-一年内应收关联方款项 $27,000.00 $3,000.00 $46,000.00 $46,000.00 $18,000.00
预付资产 $1.35M $25.23M $26.40M $26.40M $28.75M
存货 $1.94M $547,000.00 $910,000.00 $910,000.00 $6.70M
其他流动资产 $24.82M $3.02M $2.14M $2.14M $2.51M
非流动资产合计 $189.52M $193.68M $187.02M $187.02M $189.49M
固定资产净值 $145.49M $145.82M $147.27M $147.27M $162.79M
-固定资产原值 $145.49M $261.56M $259.76M $259.76M $272.04M
一年以上应收票据 $0.00 $0.00 $7.38M $7.38M $7.32M
商誉及其他无形资产 $11.84M $12.89M $13.95M $13.95M $14.48M
-其他无形资产 $11.84M $11.98M $13.04M $13.04M $13.57M
其他非流动资产 $32.19M $34.98M $18.42M $18.42M $4.91M
负债合计 $1.67B $1.52B $1.00B $1.00B $1.04B
流动负债合计 $76.73M $67.95M $61.75M $61.75M $57.13M
应付款 $13.55M $12.12M $7.38M $7.38M $6.22M
-应付账款 $12.00M $11.19M $6.98M $6.98M $5.77M
-一年内应付关联方款项 $1.55M $930,000.00 $403,000.00 $403,000.00 $443,000.00
一年内应计费用 $55.67M $34.49M $23.70M $23.70M $23.99M
短期债务及融资租赁负债 $7.51M $7.63M $7.54M $7.54M $7.32M
-一年内到期融资租赁负债 $7.51M $7.63M $7.54M $7.54M $7.32M
非流动负债合计 $1.60B $1.45B $939.72M $939.72M $985.26M
长期债务及融资租赁负债 $805.55M $711.53M $510.54M $510.54M $534.93M
-长期债务 $774.35M $678.39M $477.09M $477.09M $500.80M
-长期融资租赁负债 $31.20M $33.15M $33.45M $33.45M $34.13M
衍生产品负债 $376.39M $331.51M $104.14M $104.14M $133.48M
其他非流动负债 $415.60M $404.77M $325.04M $325.04M $316.85M
股东权益合计 -$1.05B -$869.13M -$499.57M -$499.57M -$523.41M
股东权益 -$1.05B -$870.01M -$500.47M -$500.47M -$524.32M
股本 $105,000.00 $104,000.00 $101,000.00 $101,000.00 $98,000.00
-普通股 $105,000.00 $104,000.00 $101,000.00 $101,000.00 $98,000.00
资本公积 $3.52B $3.46B $3.20B $3.20B $3.14B
留存收益 -$4.59B -$4.36B -$3.73B -$3.73B -$3.66B
不影响留存收益的损益 $27.28M $27.45M $28.96M $28.96M $5.00M
少数股东权益 $868,000.00 $880,000.00 $895,000.00 $895,000.00 $909,000.00
-累计折旧 – -$115.75M -$112.49M -$112.49M -$109.25M
-商誉 – $910,000.00 $910,000.00 $910,000.00 $910,000.00
其他流动负债 – $2.45M $3.07M $3.07M $2.12M
-其他应收款 – – – – $1.68M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 -$66.49M -$75.36M -$304.94M -$70.38M -$68.91M
持续经营经营活动现金流净额 -$66.49M -$75.36M -$304.94M -$70.38M -$68.91M
持续经营净利润 -$230.39M -$632.80M -$351.47M -$61.96M -$67.27M
持续经营损益 $44.88M $292.88M -$53.32M -$27.18M -$15.19M
折旧、折耗与摊销 $4.41M $4.38M $15.53M $3.87M $3.95M
其他非现金项目 $345.40M $9.97M $90.58M $8.24M $14.04M
营运资金变动 -$413,000.00 -$500,000.00 -$54.33M -$14.41M -$12.33M
-应收款变动 -$10.20M -$700,000.00 -$40.21M -$10.56M -$9.89M
-存货变动 $1.01M -$4.99M -$6.33M -$7.89M -$63,000.00
-预付资产变动 $1.59M $559,000.00 -$4.86M $3.06M -$4.84M
-应付账款及应计费用变动 $8.32M $7.04M $2.99M $2.90M $4.08M
-其他流动资产变动 $336,000.00 -$1.05M $803,000.00 -$16,000.00 -$324,000.00
-其他流动负债变动 -$2.06M -$1.93M -$7.21M -$1.84M -$1.79M
-其他营运资金变动 $595,000.00 $570,000.00 $477,000.00 -$68,000.00 $501,000.00
投资活动现金流净额 -$107.47M -$31.65M -$149.80M $43.57M -$181.36M
持续经营投资活动现金流净额 -$107.47M -$31.65M -$149.80M $43.57M -$181.36M
固定资产购置及出售净额 -$3.52M -$1.78M -$3.85M -$903,000.00 -$741,000.00
无形资产购置及出售净额 -$23,000.00 -$11,000.00 -$406,000.00 -$372,000.00 -$34,000.00
投资购置及出售净额 -$103.93M -$29.86M -$145.55M $44.85M -$180.59M
筹资活动现金流 $44.44M $223.93M $400.24M $54.89M $173.52M
持续经营筹资活动现金流净额 $44.44M $223.93M $400.24M $54.89M $173.52M
债务发行及偿还净额 -$12,000.00 $48,000.00 $2.86M $2.87M -$12,000.00
普通股发行净额 $45.05M $102.23M $400.56M $53.74M $173.68M
股票期权行使所得 $347,000.00 $47.52M -$2.05M -$590,000.00 -$151,000.00
其他筹资费用净额 -$940,000.00 $74.13M -$1.13M – –
期末现金余额 $76.95M $206.47M $89.43M $89.43M $61.34M
现金净变动 -$129.52M $116.92M -$54.50M $28.09M -$76.75M
期初现金余额 $206.47M $89.43M $143.91M $61.34M $138.14M
汇率变动影响 -$3,000.00 $122,000.00 $15,000.00 $5,000.00 -$56,000.00
自由现金流 -$70.03M -$77.15M -$309.19M -$71.65M -$69.68M

讨论区

暂无评论——快来第一个聊聊 IBRX。

登录后参与讨论。

Scroll to Top